ProPhase Labs, Inc. filed a Form D with the Securities and Exchange Commission on 2025-08-05.
ProPhase Labs, Inc. filed a Form D notice of an exempt securities offering with the SEC on August 5, 2025. The filing reports $3M sold. Its industry group is Biotechnology. It names TED KARKUS (Executive Officer, Director), LOUIS GECKEL (Director), WARREN HIRSCH (Director) (SEC Form D, August 5, 2025).
Is this your company?
Sell to companies like ProPhase Labs, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-08-05 · the record
Pitching, partnering or investing alongside them? See who really runs and owns ProPhase Labs, Inc.
Free to see. No signup.
More on the people and the money behind ProPhase Labs, Inc., from the filings we hold.
Biotechnology raises by companies based in New York, filed within 90 days of this one, largest first.
Get an email when ProPhase Labs, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when ProPhase Labs, Inc. raises, hires or launches. No email unless you switch it on.
Watch ProPhase Labs, Inc. →Get the full cited report on ProPhase Labs, Inc.
What the filing shows about ProPhase Labs, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on ProPhase Labs, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives ProPhase Labs, Inc.'s address as 626 Rxr Plaza, 6TH Floor, Uniondale, NY 11556.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
ProPhase Labs, Inc. is a registered filer with the SEC (CIK 868278) and has filed since 2025-07-07. 2 filings are on record, the latest on 2025-08-05.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
ProPhase Labs, Inc.'s Form D of 2025-08-05 names TED KARKUS, LOUIS GECKEL, WARREN HIRSCH and 1 more as its officers, directors or promoters.
Its new offerings report $4M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 769 filings in Biotechnology, totalled by week.
NONE OTHER THAN SALARY IN NORMAL COURSE
Checked away from the filing. What is below does not come from the record on sec.gov.
The title and description the site itself served, answering 200, after redirecting from https://prophaselabs.com. Not a cached copy and not the company's directory entry — what was live when we asked.
Ted Karkus is named as Executive Officer and Director on the Form D that ProPhase Labs, Inc. filed with the SEC on 5 August 2025, one of 4 people that filing names.
Louis Geckel is named as Director on the Form D that ProPhase Labs, Inc. filed with the SEC on 5 August 2025, one of 4 people that filing names.
Warren Hirsch is named as Director on the Form D that ProPhase Labs, Inc. filed with the SEC on 5 August 2025, one of 4 people that filing names.
Carolina Abenante is named as Director on the Form D that ProPhase Labs, Inc. filed with the SEC on 5 August 2025, one of 4 people that filing names.
4 people named on the filing — 1 holding an executive role and 3 as directors only.
Named as of the 2025-08-05 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about ProPhase Labs, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on ProPhase Labs, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on ProPhase Labs, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist ProPhase Labs, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind ProPhase Labs, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-11-01 (prophaselabs.com).
Each opens in a new tab, filled in for ProPhase Labs, Inc.. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/prophase-labs-inc-form-d-25000001